Aorn Antonio Cardarelli

Naples 80131

2 studies enrolling now · 6 studies all time

What they study most

AChR-Ab Seropositive Generalized Myasthenia Gravis, Acute Myeloid Leukemia, Generalized Myasthenia Gravis, Generalized Myasthenia Gravis (gMG), MG, Myasthenia Gravis, Myasthenia Gravis, Ocular, PAD, Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations, gMG

Studies at this site

• ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod — Recruiting now
• ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis — Recruiting now
• A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis — Running, not enrolling
• Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML — Completed
• SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients — Completed
• A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed